The randomized, double-blind, placebo-controlled ODYSSEY-HCM trial included 580 adult patients with symptomatic nonobstructive HCM.

When used with the companion app, the smart belt automatically alerts caregivers when a fall or impact is detected.

To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and promote the use of lab-grown human organoids (tiny, self-organized ...

CJD is caused by infectious proteins called prions. These proteins damage the brain and lead to fast-moving dementia.

In the past, experts from the CDC’s EpiAid program have provided short-term help to local agencies dealing with urgent public health issues.

The recall involves the "Brunch & Go" stroller toy, a set of make-believe breakfast items including avocado toast, bacon, a tomato and an egg.

Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...

After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.

Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.